کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2007972 | 1066391 | 2006 | 5 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Human VIP-α: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
زیست شیمی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Human VIP-α: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension Human VIP-α: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension](/preview/png/2007972.png)
چکیده انگلیسی
We have previously shown that self-association of human vasoactive intestinal peptide with sterically stabilized liposomes (VIP-α) alters peptide conformation from random coil in aqueous solution to α-helix. This, in turn, protects the peptide from hydrolysis and amplifies and prolongs its bioactivity. The purpose of this study was to determine whether a single, intravenous injection of low-dose human VIP-α normalizes systemic arterial pressure in anesthetized spontaneously hypertensive hamsters for a prolonged period of time in a selective fashion. We found that intravenous injection of human VIP-α, VIP alone (each, 1.0 nmol) and empty liposomes had no significant effects on mean arterial pressure (MAP) in normotensive hamsters. By contrast, human VIP-α (0.01-1.0 nmol) evoked a significant concentration-dependent decrease in MAP to the normative range in spontaneously hypertensive hamsters that lasted throughout the observation period (6 h; p < 0.05). VIP alone and empty liposomes had no significant effects on MAP in these animals. We conclude that a single, low-dose intravenous injection of human VIP-α normalizes systemic arterial pressure in spontaneously hypertensive hamsters for a prolonged period of time in a selective fashion. We suggest that human VIP-α should be further developed as a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Peptides - Volume 27, Issue 9, September 2006, Pages 2271-2275
Journal: Peptides - Volume 27, Issue 9, September 2006, Pages 2271-2275
نویسندگان
Hayat Ãnyüksel, Florence Séjourné, Hideyuki Suzuki, Israel Rubinstein,